Analgetic Dose
Showing 26 - 50 of >10,000
Severe Hemophilia A Without Inhibitor, Joint Bleed Trial in Bangkok ("Emicizumab", "HEMLIBRA®")
Recruiting
- Severe Hemophilia A Without Inhibitor
- Joint Bleed
- "Emicizumab", "HEMLIBRA®"
-
Bangkok, ThailandKing Chulalongkorn Memorial hospital
Nov 25, 2023
Non Hodgkin Lymphoma Trial (TMhuCART19-IL18)
Not yet recruiting
- Non Hodgkin Lymphoma
- TMhuCART19-IL18
- (no location specified)
Aug 2, 2023
Poliomyelitis Trial in Geelong, Melbourne (Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) (VLP-Polio), Inactivated
Not yet recruiting
- Poliomyelitis
- Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) (VLP-Polio)
- +3 more
-
Geelong, Victoria, Australia
- +1 more
Oct 30, 2023
Rheumatoid Arthritis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )
Completed
- Rheumatoid Arthritis
- LNK01001 Dose A
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
Oct 24, 2023
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)
Not yet recruiting
- Triple Negative Breast Cancer
- +13 more
- (no location specified)
Aug 29, 2023
Obstructive Sleep Apnea Trial (IHL-42X Low Dose, IHL-42X High Dose, Placebo)
Not yet recruiting
- Obstructive Sleep Apnea
- IHL-42X Low Dose
- +5 more
- (no location specified)
Nov 22, 2023
Ankylosing Spondylitis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, Placebo)
Completed
- Ankylosing Spondylitis
- LNK01001 Dose A
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
Oct 10, 2023
Esophagus Cancer, Bladder Cancer, Liver Cancer Trial (Intravenous injection of P-IL-2, P-IL-2 plus Anti-PD-1 Monoclonal
Not yet recruiting
- Esophagus Cancer
- +4 more
- Intravenous injection of P-IL-2
- P-IL-2 plus Anti-PD-1 Monoclonal Antibody
- (no location specified)
Apr 24, 2023
Appendicitis Acute Trial (Weight-adjusted low-dose contrast media paired with low-radiation dose abdomen CT)
Not yet recruiting
- Appendicitis Acute
- Weight-adjusted low-dose contrast media paired with low-radiation dose abdomen CT
- (no location specified)
May 18, 2023
CD20-positive Non-Hodgkin Lymphoma Trial in China (EX103 injection)
Recruiting
- CD20-positive Non-Hodgkin Lymphoma
- EX103 injection
-
Zhengzhou, Henan, China
- +3 more
Aug 28, 2023
Advanced Solid Tumor Trial in Kuching (BL0020)
Not yet recruiting
- Advanced Solid Tumor
-
Kuching, MalaysiaSarawak General Hospital
May 24, 2023
Hand, Foot and Mouth Disease Trial (EV71 Vaccine)
Not yet recruiting
- Hand, Foot and Mouth Disease
- EV71 Vaccine
- (no location specified)
Nov 17, 2023
Advanced Solid Tumor Trial in United States (CLN-617, Pembrolizumab)
Not yet recruiting
- Advanced Solid Tumor
-
Los Angeles, California
- +5 more
Sep 12, 2023
Evaluation of High Dose Methotrexate Toxicity
Not yet recruiting
- Methotrexate Toxicity
- blood methotrexate level and Cystatin C level
- (no location specified)
Nov 7, 2023
Head Neck Cancer, Head and Neck Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Chicago (Xevinapant, Carboplatin,
Not yet recruiting
- Head and Neck Cancer
- +2 more
- Xevinapant
- +3 more
-
Chicago, IllinoisUniversity of Chicago Medicine Comprehensive Cancer Center
Oct 25, 2023
Advanced Malignant Tumor Trial (SHR-5495 for injection)
Not yet recruiting
- Advanced Malignant Tumor
- SHR-5495 for injection
- (no location specified)
Sep 26, 2023
Advanced Solid Tumor Trial in Guangzhou (NWY001)
Not yet recruiting
- Advanced Solid Tumor
- NWY001
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Cancer
Aug 6, 2023
